Ummunity Corp is committed to developing and designing hyper-immune bovine and egg colostrum blends that could bind multiple pathogens as oral antibody packages, targeting very specific human diseases not just gastrointestinal diseases.

Thus a three step platform was created to use specially targeted specific and blended antibodies.

Specifically Targeted Broad Spectrum Packages (STBSP)

To produce high quality combinations of many different kinds of antibodies STBSP or specifically targeted broad spectrum packages was devised. These specifically targeted broad spectrum packages and could be likened to multiple polyvalent vaccines, only in that they contain large quantities of safe and effective multiple antibodies that are harvested from cows colostrum and eggs. As one antibody weighs 160,000 Daltons, this opened up the way to combine tens or hundreds of very specific antibodies and prevent pathogenic colonizing. Thus, these various groups or clades of antibodies can be targeted at a very large and wide range of specific diseases in one package safe and effectively.
Produce one major kind of antibody from each animal
Select antibodies or groups of antibodies designed for very specific pathogens
Tens or hundreds of specific antibodies can be used in varying packages

Antibody Preservation Control (APC)

Critical to the final product was the efficacy of antibodies. Antibodies have a “half-life” and begin to decay as soon as extracted from their source. So a process was designed to preserve these antibodies so as to not lose or affect efficacy, safety, potency and quality otherwise they couldn’t be guaranteed. This process is called APC or Antibody Preservation Control. This process also eliminates the need for cool storage or special handling and requires no expiry date. APC antibody packages are ready to work until the package is opened.

Universal Immunity Oral Antibodies Packages (UIOAP)

However due to the vast array of clades or strains of pathogens (diseases) and their corresponding antibodies, – UIOAP or Universal Immunity Oral Antibodies Packaging was designed for the many different kinds of antibodies packages required corresponding diseases. Using proprietary formulations to package for example antibodies for Ebola strains, Influenzas strains, immune deficiency strains, a true full broad spectrum of packages could be used to treat and prevent pathogens with different packages. Likewise countries or global regions such as in the US there are over 31 major pathogens in food borne illnesses or in Canada where a minimum of 12 major diarrhea diseases strains has caused a major enteric problem it is possible to now make special packages to prevent and treat these pathogens. Also, global scientists have also discovered that of the over 200 strains of certain HIV pathogens a dozen or so are responsible for the infections as they are called the dominant strains.


We know that scientifically more antibodies means a faster and stronger immune response.

We also have a process, fruit of 20 years of research, to produce targeted antibodies.

Yet, we cannot claim that our product provides a faster and stronger immune system. To make such claim, any product must go through drug certification and clinical trials.

We are working towards the release of 5 targeted drugs.


Product description Status
Product Platform Enabling Discovery trials Pretrials Clinical trials P1 Clinical trials P2
Universal Diapak STBSP/APC 25+ Enteric diseases
Universal Opak STBSP/APC 30+ Antigens
Universal Flupak STBSP/APC 25+ Antigens
Universal PID-AIDSpak STBSP/APC 30+ Antigens
Universal Cancerpak STBSP/APC 50+ Antigens

Contact us

At this stage of our project support is what we need. Wether you want to publish our story, get more information, join our team, invest or simply encourage us, do not hesitate to contact us. Thank you!

Company Info

Wilmington, DE, USA
Vancouver, BC, Canada
Wisconsin, USA
Ownership: Privately held
Investors: Crowdfunding and individual investors
Funds Raised: Available under confidentiality
Employees: 10+
Phone: 302-887-9159


Investors relations
Marcel Marais, COO
Todd Hunter, CTO
Austin Stelere, PR Manager
Chief Technical Officer
Todd Hunter, CTO
Corporate Counsel
Cris Rizzi, Firm’s Lawyer

General inquiries



Thank you for your interest in this project, the following material is currently available for download:

More resources will be added as we release our results.

Cookies policy

About cookies

This website uses cookies. By using this website and agreeing to this policy, you consent to Ummunity Corporation’s use of cookies in accordance with the terms of this policy.

Cookies are files sent by web servers to web browsers, and stored by the web browsers.
The information is then sent back to the server each time the browser requests a page from the server. This enables a web server to identify and track web browsers.
There are two main kinds of cookies: session cookies and persistent cookies. Session cookies are deleted from your computer when you close your browser, whereas persistent cookies remain stored on your computer until deleted, or until they reach their expiry date.

Cookies on our website

Ummunity Corporation uses cookies on this website, for the following purposes:

  • Provide better web services
  • Remember your preferences such as languages
  • Monitor website performances
  • Monitor traffic and visitors

Third party cookies

Ummunity Corporation uses Google and AWS services to analyse the use of this website. Google generates statistical and other information about website use by means of cookies, which are stored on users’ computers. The information generated relating to our website is used to create reports about the use of the website. Google will store and use this information. Google’s privacy policy is available at:

Refusing cookies

Most browsers allow you to refuse to accept cookies.
In Internet Explorer, you can refuse all cookies by clicking “Tools”, “Internet Options”, “Privacy”, and selecting “Block all cookies” using the sliding selector.
In Firefox, you can adjust your cookies settings by clicking “Tools”, “Options” and “Privacy”.
Blocking cookies will have a negative impact upon the usability of some websites.

Legal terms


These terms and conditions govern your use of this website; by using this website, you accept these terms and conditions in full. If you disagree with these terms and conditions or any part of these terms and conditions, you must not use this website.

This website uses cookies. By using this website and agreeing to these terms and conditions, you consent to Ummunity Corp’s use of cookies in accordance with the terms of Ummunity Corp’s cookies policy.

License to use this website

Unless otherwise stated, Ummunity Corp and/or its licensors own the intellectual property rights in the website and material on the website. Subject to the license below, all these intellectual property rights are reserved.

You may view, download for caching purposes only, and print pages from the website for your own personal use, subject to the restrictions set out below and elsewhere in these terms and conditions.

You must not:

Republish material from this website (including republication on another website)
Sell, rent or sub-license material from the website
Show any material from the website in public
Reproduce, duplicate, copy or otherwise exploit material on this website for a commercial purpose
Edit or otherwise modify any material on the website
Redistribute material from this website

Acceptable use

You must not use this website in any way that causes, or may cause, damage to the website or impairment of the availability or accessibility of the website; or in any way which is unlawful, illegal, fraudulent or harmful, or in connection with any unlawful, illegal, fraudulent or harmful purpose or activity.

You must not use this website to copy, store, host, transmit, send, use, publish or distribute any material which consists of (or is linked to) any spyware, computer virus, Trojan horse, worm, keystroke logger, rootkit or other malicious computer software.

You must not conduct any systematic or automated data collection activities (including without limitation scraping, data mining, data extraction and data harvesting) on or in relation to this website without Ummunity Corp express written consent.

You must not use this website to transmit or send unsolicited commercial communications.

You must not use this website for any purposes related to marketing without Ummunity Corp express written consent.

Restricted access

Access to certain areas of this website is restricted. Ummunity Corp reserves the right to restrict access to other areas of this website, or indeed this entire website, at Ummunity Corp discretion.

If Ummunity Corp provides you with a user ID and password to enable you to access restricted areas of this website or other content or services, you must ensure that the user ID and password are kept confidential.

Ummunity Corp may disable your user ID and password in Ummunity Corp sole discretion without notice or explanation.

No warranties

This website is provided “as is” without any representations or warranties, express or implied. Ummunity Corp makes no representations or warranties in relation to this website or the information and materials provided on this website.

Without prejudice to the generality of the foregoing paragraph, Ummunity Corp does not warrant that:

This website will be constantly available, or available at all
The information on this website is complete, true, accurate or non-misleading.
Nothing on this website constitutes, or is meant to constitute, advice of any kind.

Limitations of liability

Ummunity Corp will not be liable to you (whether under the law of contact, the law of torts or otherwise) in relation to the contents of, or use of, or otherwise in connection with, this website:

To the extent that the website is provided free-of-charge, for any direct loss
For any indirect, special or consequential loss
For any business losses, loss of revenue, income, profits or anticipated savings, loss of contracts or business relationships, loss of reputation or goodwill, or loss or corruption of information or data.
These limitations of liability apply even if Ummunity Corp has been expressly advised of the potential loss.


By using this website, you agree that the exclusions and limitations of liability set out in this website disclaimer are reasonable.

If you do not think they are reasonable, you must not use this website.

Other parties

You accept that, as a limited liability entity, Ummunity Corp has an interest in limiting the personal liability of its officers and employees. You agree that you will not bring any claim personally against Ummunity Corp officers or employees in respect of any losses you suffer in connection with the website.

Without prejudice to the foregoing paragraph, you agree that the limitations of warranties and liability set out in this website disclaimer will protect Ummunity Corp officers, employees, agents, subsidiaries, successors, assigns and sub-contractors as well as Ummunity Corp.

Unenforceable provisions

If any provision of this website disclaimer is, or is found to be, unenforceable under applicable law, that will not affect the enforceability of the other provisions of this website disclaimer.


You hereby indemnify Ummunity Corp and undertake to keep Ummunity Corp indemnified against any losses, damages, costs, liabilities and expenses (including without limitation legal expenses and any amounts paid by Ummunity Corp to a third party in settlement of a claim or dispute on the advice of Ummunity Corp legal advisers) incurred or suffered by Ummunity Corp arising out of any breach by you of any provision of these terms and conditions, or arising out of any claim that you have breached any provision of these terms and conditions.

Breaches of these terms and conditions

Without prejudice to Ummunity Corp other rights under these terms and conditions, if you breach these terms and conditions in any way, Ummunity Corp may take such action as Ummunity Corp deems appropriate to deal with the breach, including suspending your access to the website, prohibiting you from accessing the website, blocking computers using your IP address from accessing the website, contacting your internet service provider to request that they block your access to the website and/or bringing court proceedings against you.


Ummunity Corp may revise these terms and conditions from time-to-time. Revised terms and conditions will apply to the use of this website from the date of the publication of the revised terms and conditions on this website. Please check this page regularly to ensure you are familiar with the current version.


Ummunity Corp may transfer, sub-contract or otherwise deal with Ummunity Corp rights and/or obligations under these terms and conditions without notifying you or obtaining your consent.

You may not transfer, sub-contract or otherwise deal with your rights and/or obligations under these terms and conditions.


If a provision of these terms and conditions is determined by any court or other competent authority to be unlawful and/or unenforceable, the other provisions will continue in effect. If any unlawful and/or unenforceable provision would be lawful or enforceable if part of it were deleted, that part will be deemed to be deleted, and the rest of the provision will continue in effect.

Entire agreement

These terms and conditions constitute the entire agreement between you and Ummunity Corp in relation to your use of this website, and supersede all previous agreements in respect of your use of this website.

Law and jurisdiction

These terms and conditions will be governed by and construed in accordance with the law of New Jersey, USA, and any disputes relating to these terms and conditions will be subject to the exclusive jurisdiction of the courts of New Jersey.

Forward Looking and Cautionary statements

Our news release may include certain “Forward-looking statements” within the meaning of Section 21E of the United States Securities Exchange Act, as amended. All statements, other than statements of historical fact, included in this release are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. This notice expressly qualifies all forward-looking statements in this release.

Ummunity Corp


Thank you for your interest in this project, we are currently in great need of funding in order to move forward with the release of our products.

If yourself or your entourage is interested in investing in our project please contact us. More material will be provided, meanwhile you can download our presentation.

If you want to contribute without investing we will be glad to receive your donation.


Thank you for your interest in this project, if you would like to spread the word and write an article about us please download our presentation, all written content within is free to use for media purposes.

Additionally we will be glad to answer your questions if you contact us.


Are Ummunity’s antibodies the same as the ones in my body?
How are antibodies collected?
Are Ummunity’s antibodies drugs?
Is Ummunity’s activity cruel for animals?
Do oral antibodies have side effects?

Are Ummunity’s antibodies the same as the ones in my body?

Although they are slightly different, our antibodies can still hook the same way to antigens and be digested by human phagocytes. We use antibodies that come from cow colostrum, milk and chicken eggs. The modern dairy milk processes and cooking kill them. We have found a way to harness their power, preserve them and to use them to fight, prevent and treat diseases.

How are antibodies collected?

Antibodies are collected from milk and eggs. Cows and chickens are vaccinated against specific human diseases, so their body start producing antibodies. Those antibodies are especially concentrated inside eggs and colostrum (colostrum is the name of the milk produced within the first 60 Liters after a calf’s birth). The concentration of antibodies inside eggs and colostrum is 100 times higher than in regular milk. It is there to help protect the young calf and young chick during the development of their immune systems.

We use patented and secret processes to extract and preserve those antibodies from eggs and colostrum. Then we combine different antibodies (for example from a cow vaccinated against the flu and a chicken vaccinated against diarrhea) to create packages of antibodies targeting a wide range of antigens.

Are Ummunity’s antibodies drugs?

First, let us examine what is meant by the word ‘drug.’ Drugs are not classified by how they are made, but rather by how they work. Any product claiming to protect against diseases must be classified as a ‘drug’ and undergo clinical trials.

We are currently working towards the release of 5 drugs. After this long process, our antibodies will technically be labeled as ‘drugs.’ Yet the antibodies we produce are simply sub-products of milk and eggs, to which we have added nothing. Therefore our product is just like regular food.

Is Ummunity’s activity cruel for animals?

No. Ummunity’s needs from animals are limited to eggs and milk, but the methods used are no different from the ones used at egg and milk farms. Ummunity does not currently own it’s own farms and partners with high quality, family-owned farms in the USA committed to animal rights.

Do oral antibodies have side effects?

People who are allergic to eggs or cow’s milk are likely to to be allergic to our oral antibodies. According to the American Dairy Association about 5% of the US population is allergic to cow’s milk. Experts estimate that as many as 2 percent of children are allergic to eggs with about 70 percent of children with an egg allergy will outgrow the condition by age 16. Still any medication or foods that some adults and children take, due to special health conditions, may be prohibited by your doctor. Always get professional medical opinions from your physician if that is your case. Further Clinical Trials will establish what side effects there are. They will be announced.